Kamran Ahmed, MD
@kahmedmd.bsky.social
Radiation Oncologist and Vice Chair of Clinical Research @MoffittRadOnc @moffittnews.bsky.social
Reposted by Kamran Ahmed, MD
Late-stage #breastcancer patients are more often affected by 🧠 brain #metastases than previously believed, a new study led by @kahmedmd.bsky.social from 🇺🇸 @moffittnews.bsky.social finds. The researchers suggest that current #MRI #screening guidelines should reflect this.
Why late-stage breast cancer patients should receive routine brain MRI screening
A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed.
dlvr.it
February 1, 2025 at 7:30 AM
Late-stage #breastcancer patients are more often affected by 🧠 brain #metastases than previously believed, a new study led by @kahmedmd.bsky.social from 🇺🇸 @moffittnews.bsky.social finds. The researchers suggest that current #MRI #screening guidelines should reflect this.
Reposted by Kamran Ahmed, MD
Small but interesting single arm study -
Intratumoral delivery of dendritic cells + anti-HER2 antibodies alone resulted in complete responses in 3 of 12 patients!
Congrats to Heather Han & colleagues at Moffitt.
jamanetwork.com/journals/jam...
Intratumoral delivery of dendritic cells + anti-HER2 antibodies alone resulted in complete responses in 3 of 12 patients!
Congrats to Heather Han & colleagues at Moffitt.
jamanetwork.com/journals/jam...
Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer
This nonrandomized clinical trial examines the safety, immunogenicity, and preliminary efficacy of intratumoral delivery of conventional type 1 dendritic cells in combination with ERBB2-targeted thera...
jamanetwork.com
December 5, 2024 at 9:41 PM
Small but interesting single arm study -
Intratumoral delivery of dendritic cells + anti-HER2 antibodies alone resulted in complete responses in 3 of 12 patients!
Congrats to Heather Han & colleagues at Moffitt.
jamanetwork.com/journals/jam...
Intratumoral delivery of dendritic cells + anti-HER2 antibodies alone resulted in complete responses in 3 of 12 patients!
Congrats to Heather Han & colleagues at Moffitt.
jamanetwork.com/journals/jam...